Analyses | Medicine and healthcare | 2017-05-12 | HKEJ

At what price? The skyrocketing cost of orphan drugs



Medicines to treat rare diseases can cost up to several million dollars per year. These medicines, also known as ‘orphan drugs’, are believed to be expensive because of favourable policies to encourage their development, which help drive up their prices. Actually, there are possible ways to reduce costs. In addition to subsidies, support from the Government and society at large can help reduce the burden on patients. 

The full version of the commentary is in Chinese only.